Dupilumab reduces exacerbations in COPD with type 2 inflammation
1. In this randomized controlled trial, patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who received dupilumab ...
1. In this randomized controlled trial, patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation who received dupilumab ...
1. In this randomized controlled trial, CM313, an anti-CD38 monoclonal antibody therapy, was associated with rapid recovery of platelet counts ...
1. In this randomized controlled trial, exposure to heat that increased core temperature by 1.5C in healthy participants was associated ...
1. In this randomized controlled trial, adults with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) who received pulmonologist-directed treatment ...
1. In two clinical trials, iptacopan in patients with paroxysmal nocturnal hemoglobinuria (PNH) improved hemoglobin levels compared to anti-C5-treated patients ...
1. This retrospective cohort study found that the addition of hyperbaric oxygen therapy (HBOT) to surgery in patients with necrotizing ...
1. In this randomized controlled trial, primary biliary cholangitis (PBC) patients who received elafibranor had significantly improved serum markers of ...
1. In this retrospective cohort study, patients achieving surgical remission of Cushing’s disease (CD) had a higher incidence of autoimmune ...
1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo ...
1. In this cohort study, estimated glomerular filtration rate based on both creatinine and cystatin C (eGFRcr-cys ) was more strongly ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.